Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Aptose Biosciences Inc (APS) Ord Shares NPV

Sell:8.02 CAD Buy:8.04 CAD Change: 0.1 CAD (1.23%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:8.02 CAD
Buy:8.04 CAD
Change: 0.1 CAD (1.23%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:8.02 CAD
Buy:8.04 CAD
Change: 0.1 CAD (1.23%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities. The Company develops therapeutics focused on epigenetic processes and signal transduction abnormalities at the edge of cancer research, coupled with companion diagnostics to identify the optimal patient population for its products. The Company's APTO-253 is a small molecule that can induce expression of the genes that codes for the Kruppel-like factor 4 (KLF4) master transcription factor and the p21 cell cycle inhibitor protein.

Contact details

Address:
251 Consumers Rd Suite 1105
NORTH YORK
M2J 4R3
Canada
Telephone:
+1 (647) 4799828
Website:
https://aptose.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
APS
ISIN:
CA03835T2002
Market cap:
781.14 million CAD
Shares in issue:
88.86 million
Sector:
Biotechnology
Exchange:
Toronto Stock Exchange
Country:
Canada
Currency:
Canadian dollars
Indices:
n/a

Key personnel

  • William Rice
    Chairman of the Board, President, Chief Executive Officer
  • Gregory Chow
    Chief Financial Officer, Executive Vice President
  • Rafael Bejar
    Senior Vice President, Chief Medical Officer
  • Jotin Marango
    Senior Vice President, Chief Business Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.